latest news releases from the newsroom
PICO Holdings, Inc.
PICO Holdings, Inc. Announces Public Offering of 3,055,556 Shares
LA JOLLA, Calif., June 5, 2009 (GLOBE NEWSWIRE) -- PICO Holdings, Inc. (Nasdaq:PICO) today announced that it has priced a public offering of 3,055,556 shares of its common stock at $27.00 per share. The approximately $77.9 million of net proceeds, after deducting the underwriting discounts and commissions and estimated offering expenses, will be used for general corporate purposes. The offering is expected to close on or about June 10, 2009, subject to the satisfaction of customary closing conditions.
Neutral Tandem Management to Speak At the 2009 William Blair Growth Stock Conference
CHICAGO, June 5, 2009 (GLOBE NEWSWIRE) -- Rian Wren and Robert Junkroski, Neutral Tandem's (Nasdaq:TNDM) Chief Executive Officer and Chief Financial Officer, respectively, will provide an overview and update of the Company's business at the William Blair Growth Stock Conference in Chicago, Illinois on Wednesday, June 10, 2009.
Savient Pharmaceuticals Inc
Savient Announces Election of Dr. Ginger D. Constantine to Board of Directors
EAST BRUNSWICK, N.J., June 5, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Ginger D. Constantine, M.D. has been elected to the Company's Board of Directors. Dr. Constantine currently serves as Vice President of Women's Health & Bone Repair Medical Research at Wyeth Research, a division of Wyeth Pharmaceuticals. Since 1992, Dr. Constantine has held various management positions of increasing responsibility in the therapeutic areas of rheumatology, metabolism and bone repair within the Wyeth Pharmaceuticals and Wyeth Research organizations. Prior to joining Wyeth, Dr. Constantine was a practicing physician specializing in Rheumatology and Internal Medicine and has authored a number of articles, abstracts as well as presentations, in the area of rheumatology and arthritis for peer reviewed publications and meetings.